- Home
- DKS vs UTHR Comparison
DKS vs UTHR Comparison
Compare DKS & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DKS
- UTHR
- Stock Information
- Founded
- DKS 1948
- UTHR 1996
- Country
- DKS United States
- UTHR United States
- Employees
- DKS N/A
- UTHR N/A
- Industry
- DKS Other Specialty Stores
- UTHR Biotechnology: Pharmaceutical Preparations
- Sector
- DKS Consumer Discretionary
- UTHR Health Care
- Exchange
- DKS Nasdaq
- UTHR Nasdaq
- Market Cap
- DKS 14.6B
- UTHR 13.8B
- IPO Year
- DKS N/A
- UTHR 1999
- Fundamental
- Price
- DKS $227.52
- UTHR $312.23
- Analyst Decision
- DKS Buy
- UTHR Buy
- Analyst Count
- DKS 19
- UTHR 13
- Target Price
- DKS $234.50
- UTHR $382.00
- AVG Volume (30 Days)
- DKS 1.2M
- UTHR 762.5K
- Earning Date
- DKS 08-28-2025
- UTHR 07-30-2025
- Dividend Yield
- DKS 2.13%
- UTHR N/A
- EPS Growth
- DKS 16.10
- UTHR 17.94
- EPS
- DKS 14.00
- UTHR 25.63
- Revenue
- DKS $13,599,143,000.00
- UTHR $3,077,800,000.00
- Revenue This Year
- DKS $5.01
- UTHR $14.37
- Revenue Next Year
- DKS $3.46
- UTHR $6.59
- P/E Ratio
- DKS $16.26
- UTHR $12.18
- Revenue Growth
- DKS 3.33
- UTHR 17.62
- 52 Week Low
- DKS $166.37
- UTHR $266.98
- 52 Week High
- DKS $254.60
- UTHR $417.82
- Technical
- Relative Strength Index (RSI)
- DKS 62.96
- UTHR 58.33
- Support Level
- DKS $218.50
- UTHR $303.59
- Resistance Level
- DKS $229.39
- UTHR $317.31
- Average True Range (ATR)
- DKS 5.20
- UTHR 7.91
- MACD
- DKS 0.24
- UTHR 0.90
- Stochastic Oscillator
- DKS 90.90
- UTHR 80.53
About DKS Dick's Sporting Goods Inc
Dick's Sporting Goods retails athletic apparel, footwear, and equipment for sports. Dick's operates digital platforms, about 720 stores under its namesake brand (including outlet stores and House of Sport), and about 130 specialty stores under the Golf Galaxy and other nameplates. Dick's carries private-label merchandise and national brands such as Nike, The North Face, Under Armour, Callaway Golf, and TaylorMade. Based in the Pittsburgh area, Dick's was founded in 1948 by the father of current executive chair and controlling shareholder Edward Stack.
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.